Mallinckrodt PLC

Pharmaceuticals
United Kingdom
Earnings Per Share Growth (%)-88%
Cost of Goods Sold (US$ Millions)$1,493
Current Liabilities (US$ Millions)$929
Total Assets (US$ Millions)$1,846
Long Term Debt$6,474
Return on Equity6.55%
Revenue (US$ Millions)$3,347
Total Company Assets$16,404
Revenue Growth (%)31.75%
Net Income (US$ Millions)$325
Earnings Per Share (US$)($88)
Total Equity (US$ Millions)$5,311
Profit Margin (%)9.70%
Debt To Equity Ratio (%)1.22%
Inventory Turnover$282